Background The increased life expectancy of people with intellectual disability intensifies
the need for age‐specific support. Research on effects of support strategies on quality of life …

Background People with intellectual disability (ID) are at increased risk of exposure to
psychotropic drugs and psychotropic polypharmacy because of the higher prevalence of …

Aims The drug burden index (DBI) is a dose‐related measure of anticholinergic and
sedative drug exposure. This cross‐sectional study described DBI in older adults with …

Background Older people (ie≥ 40 years) with intellectual disability have unique medication
needs and may experience high levels of potentially inappropriate prescribing. Despite the …

Introduction The Healthy Ageing and Intellectual Disability (HA-ID) study is a prospective
multicentre cohort study in the Netherlands that started in 2008, including 1050 older adults …

Background Psychotropic medication is frequently administered to people with intellectual
disability with mental health and/or behavioural problems, instead of other non …

Background Older people have a greater disease burden and are more likely than younger
to be prescribed medications. They are also more sensitive to adverse effects. With this in …

Background Mental health services in people with intellectual disabilities (ID) are frequently
limited to psychotropic medication (PM), especially antipsychotics. The objectives of this …

Background Falls are the most common cause of injury for older people in the general
population as well as among those with intellectual disability. There are many risk factors for …

Purpose The prescription of potentially inappropriate medications (PIMs) is associated with
an increase in adverse events, prescribing cascades, high health-care costs, morbidity, and …